Berlin-based federated computing startup, Apheris, has successfully closed a $20.8 million Series A funding round, marking a significant milestone in its mission to transform data-driven solutions in the life sciences industry.
The funding round saw robust participation from leading investors, with OTB Ventures and eCapital co-leading the effort. Other notable contributors included Octopus Ventures and Heal Capital, signaling strong confidence in Apheris’ innovative approach to secure and collaborative data usage.
Apheris, co-founded by CEO Robin Röhm and CTO Michael Höh, is at the forefront of developing federated computing technologies designed to bridge organizational data silos. Unlike traditional data-sharing methods, the company’s platform facilitates secure and private access to data without requiring centralization.
At the heart of its offering is the Apheris Compute Gateway, a product designed to uphold the highest standards of data privacy, security, and governance. This solution ensures that only pre-approved computations are executed on sensitive data, empowering organizations to derive machine learning (ML)-powered insights without compromising compliance.
The life sciences sector often grapples with stringent regulations surrounding data privacy and security. Apheris’ federated approach enables institutions to collaborate on ML and analytics projects while maintaining full control over their proprietary data.
Through its innovative technology, Apheris eliminates the need for organizations to share raw data, fostering partnerships that unlock new possibilities for research and development. This capability is particularly critical in drug discovery, clinical trials, and genomics, where data integrity and compliance are non-negotiable.
The significant investment from leading venture capital firms underscores Apheris’ potential to redefine data utilization in heavily regulated industries. OTB Ventures and eCapital, as co-leaders of the round, emphasized their support for Apheris’ vision to enable secure, scalable, and privacy-centric data collaborations across organizational boundaries.
With the Series A funding, Apheris plans to accelerate the development of its federated computing platform, expand its market reach, and enhance its capabilities to address the complex needs of the life sciences domain. The company is also expected to explore opportunities to apply its technology in adjacent sectors where data security and collaboration are paramount.
Apheris’ success highlights the growing demand for federated computing solutions that strike a balance between data privacy and collaboration. As organizations increasingly seek to leverage data for competitive advantage, Apheris offers a pathway to unlock the full potential of analytics and machine learning without sacrificing security or governance.
The $20.8 million Series A funding round positions Apheris as a leader in federated computing for the life sciences sector. By addressing critical challenges around data privacy and compliance, the company is poised to drive innovation and redefine how organizations collaborate on sensitive data. With strong backing from top-tier investors, Apheris is set to make significant strides in the evolving landscape of data-driven research and development